ライフサイエンスコーパス: beta3 adrenoceptor

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 in the SAT and very little expression of the beta3-adrenoceptor.

2 a-antagonists have agonist properties at the beta3-adrenoceptor.

3 e of two active conformational states of the beta3-adrenoceptor.

4 ative beta4-adrenoceptor) that resembles the beta3-adrenoceptor.

5 tive beta4-adrenoceptor is distinct from the beta3-adrenoceptor.

6 drenoceptor is genetically distinct from the beta3-adrenoceptor.

7 rom the other two subtypes difficult and the beta3-adrenoceptor a less-understood subtype.

8 Administration of the murine-selective beta3 adrenoceptor agonist CL-316,243 corrects obesity a

9 he beta1-adrenoceptor agonist dobutamine and beta3-adrenoceptor agonist BRL 37344A had little effect

10 ater by intra-BAT injections of the specific beta3-adrenoceptor agonist CL316,243 in one pad and the

11 ocal metabolic effects of a highly selective beta3-adrenoceptor agonist in humans.

12 The effects of a highly selective beta3-adrenoceptor agonist on insulin action, energy met

13 Cold- and beta3-adrenoceptor agonist-induced sympathetic activatio

14 s, but with limited clinical experience, are beta3 adrenoceptor agonists and phosphodiesterase type 5

15 beta3-Adrenoceptor agonists have recently been introduce

16 ker that causes agonist effects through both beta3-adrenoceptors and cardiac putative beta4-adrenocep

17 for future studies to better understand the beta3-adrenoceptor as a novel pharmacological target.

18 ased after activation of adipocyte-expressed beta3 adrenoceptors by catecholamines, and identified eo

19 Stimulation of beta3-adrenoceptors by selective agonists improves insul

20 First, the ligand-recognition profile of beta3-adrenoceptors differs considerably from that of th

21 er, these experiments suggest that the human beta3-adrenoceptor exists in at least two different agon

22 agonist effects in mice lacking a functional beta3-adrenoceptor gene (beta3 KO).

23 ociation between the Trp64Arg variant of the beta3-adrenoceptor gene and visceral obesity.

24 The role of beta3-adrenoceptor gene polymorphisms has insufficiently

25 ypothesis that postmenopausal women with the beta3-adrenoceptor gene variant (Trp64Arg) have reduced

26 ion, older obese women carrying the Trp64Arg beta3-adrenoceptor gene variant have an impaired capacit

27 A beta3 adrenoceptor has been identified and cloned.

28 tagonist affinity measurements varied at the beta3-adrenoceptor in a manner similar to those observed

29 mpathetic ganglia neurons and an increase of beta3-adrenoceptor in the SAT.

30 Second, the expression pattern of beta3-adrenoceptors is more restricted than that of othe

31 Third, beta3-adrenoceptors lack the phosphorylation sites invol

32 Importantly, the effect of beta3-adrenoceptor on mTOR complex 2 is independent of t

33 This article discusses three aspects of beta3-adrenoceptor pharmacology.

34 Alprenolol inhibited fenoterol-induced beta3-adrenoceptor responses while acting as an agonist

35 In this respect, the human beta3-adrenoceptor seems similar to the human beta1-adre

36 efore examined the pharmacology of the human beta3-adrenoceptor stably expressed in Chinese hamster o

37 We show that beta3-adrenoceptors stimulate glucose uptake in brown ad

38 pamycin (mTOR) complex 2 has a novel role in beta3-adrenoceptor-stimulated glucose uptake in brown ad

39 Both parts are essential for beta3-adrenoceptor-stimulated glucose uptake.

40 Whether selective beta3-adrenoceptor stimulation exerts metabolic actions

41 onfounding factor in previous studies of the beta3-adrenoceptor Trp64Arg variant and energy expenditu

42 Their target, the beta3-adrenoceptor, was discovered much later than beta1

43 arently differs between the human and rodent beta3-adrenoceptor, yielding considerable species differ

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。